Department of Systems Biotechnology and Center for Antibiotic Resistome, Chung-Ang University, Anseong, Republic of Korea.
ISME J. 2018 Jan;12(1):267-276. doi: 10.1038/ismej.2017.168. Epub 2017 Oct 13.
The environmental resistome has been recognized as the origin and reservoir of antibiotic resistance genes and considered to be dynamic and ever expanding. In this study, a targeted gene sequencing approach revealed that the polymorphic diversity of the aminoglycoside-inactivating enzyme AAC(6')-Ib was ecological niche-specific. AAC(6')-Ib-cr, previously known as a clinical variant, was prevalent in various soils and the intestines of chickens and humans, suggesting that this variant might not have arisen from adaptive mutations in the clinic but instead originated from the environment. Furthermore, ecologically dominant polymorphic variants of AAC(6')-Ib were characterized and found to display different substrate specificities for quinolones and aminoglycosides, conferring the altered resistance spectra. Interestingly, a novel variant with the D179Y substitution showed an extended resistance spectrum to the recently developed fluoroquinolone gemifloxacin. Our results suggest that soil and animal microbiomes could be major reservoirs of antibiotic resistance; polymorphic diversity expands the antibiotic resistome in the environment, resulting in the potential emergence of novel resistance.
环境耐药组已被认为是抗生素耐药基因的起源和储存库,并且被认为是动态的和不断扩张的。在这项研究中,一种靶向基因测序方法表明,氨基糖苷类钝化酶 AAC(6')-Ib 的多态性多样性具有生态位特异性。AAC(6')-Ib-cr,以前称为临床变异,在各种土壤和鸡和人类的肠道中普遍存在,这表明该变异可能不是在临床上从适应性突变中产生的,而是来自环境。此外,还对 AAC(6')-Ib 的生态优势多态性变异体进行了表征,并发现它们对喹诺酮类药物和氨基糖苷类药物的底物特异性不同,从而赋予了改变的耐药谱。有趣的是,具有 D179Y 取代的新型变异体对最近开发的氟喹诺酮类药物 gemifloxacin 表现出扩展的耐药谱。我们的研究结果表明,土壤和动物微生物组可能是抗生素耐药性的主要储存库;多态性多样性扩展了环境中的抗生素耐药组,从而导致新的耐药性的出现。